RIVOCEL
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Mar 2022)
What this means for you
This application is over — abandoned 21 Mar 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88238667
- Mark type
- Stylized text
- Filed
- 21 Dec 2018
- Published for opposition
- 22 Jun 2021
- Abandoned
- 21 Mar 2022
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for immunotherapy, including T Cell therapy
Owner
- Bellicum Pharmaceuticals, Inc., Houston, TX, US
- Bellicum Pharmaceuticals, Inc., Houston, TX, US
Prosecution history
- 21 Mar 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Mar 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Aug 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Jun 2021 — PUBLISHED FOR OPPOSITION
- 02 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Oct 2020 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 15 Apr 2020 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 25 Sept 2019 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 19 Mar 2019 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 19 Mar 2019 — LETTER OF SUSPENSION E-MAILED
- 19 Mar 2019 — SUSPENSION LETTER WRITTEN
- 18 Mar 2019 — ASSIGNED TO EXAMINER
- 14 Jan 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED